Results 171 to 180 of about 15,270,083 (265)

Sustaining organizational change: testing a provisional model in manufacturing companies

open access: yes, 2015
This paper details a study into the major factors that help to sustain major manufacturing management change initiatives over a prolonged period.
BELVEDERE, VALERIA   +6 more
core  

ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases: An OECD Best Practice for Integrated Care for Chronic Diseases. [PDF]

open access: yesClin Transl Allergy
Bousquet J   +155 more
europepmc   +1 more source

Using Kotter's Change Management Framework to Redesign Departmental GME Recruitment. [PDF]

open access: yesJ Grad Med Educ, 2023
Miles MC   +8 more
europepmc   +1 more source

Acute Kidney Injury After Mechanical Thrombectomy for Stroke in Patients With Pre‐Existing Renal Impairment

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Acute kidney injury (AKI) is a common but often underrecognized complication in ischemic stroke patients undergoing mechanical thrombectomy, particularly among those with pre‐existing renal impairment. This study evaluated the incidence, risk factors, and clinical impact of AKI in this high‐risk population.
Michał Borończyk   +10 more
wiley   +1 more source

Management of IT-enabled Change in a Public Organization in Tanzania

open access: yes, 2007
The implementation of Information Technology (IT) is always associated with organisational change issues and in developing countries this is even more complex due to poorer and less established IT resources and governance.
Rusu, Lazar,, Nfuka, Edephonce,
core  

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Change Management and Innovation in Graduate Medical Education. [PDF]

open access: yesJ Grad Med Educ
Caretta-Weyer HA   +5 more
europepmc   +1 more source

Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP‐1 Receptor Agonists

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy